Jon Jones Notified of Potential Doping Violation For UFC 214
UFC light heavyweight champion Jon Jones has failed a drug test for steroids, a UFC official today told MMAjunkie.
The UFC later confirmed the news in a statement on its web site.
The UFC organization was notified today that the U.S. Anti-Doping Agency (USADA) has informed Jon Jones of a potential Anti-Doping Policy violation stemming from an in-competition sample collected following his weigh-in on July 28, 2017.
USADA, the independent administrator of the UFC Anti-Doping Policy, will handle the results management and appropriate adjudication of this case involving Jones, as it relates to the UFC Anti-Doping Policy and future UFC participation. Under the UFC Anti-Doping Policy, there is a full and fair legal process that is afforded to all athletes before any sanctions are imposed. The California State Athletic Commission (CSAC) also retains jurisdiction over this matter as the sample collection was performed the day before Jones’ bout at UFC 214 in Anaheim, CA, and USADA will work to ensure that the CSAC has the necessary information to determine its proper judgment of Jones’ potential anti-doping violation.
Jones failed a test conducted by the U.S. Anti-Doping Agency, testing positive for the anabolic steroid turinabol. It’s his second positive steroids test following UFC 200, where he was stripped of the interim belt prior to a scheduled title unifier against Daniel Cormier, and his third overall failed drug test after testing positive for cocaine following a win over Cormier at UFC 182.
TMZ was first to report the news of this latest positive test, which comes one month after Jones recaptured the light heavyweight title from Cormier with a third-round knockout at UFC 214. A request for comment from the California State Athletic Commission, which regulated the bout, was not immediately returned.
Cormier and his reps also did not immediately return calls requesting comment.
Jones drew a one-year ban for his first positive steroids test after a USADA arbitrator ruled he did not intentionally dope, but was negligent in taking a sexual enhancement pill prior to UFC 200. In a tearful press conference, Jones denied using performance enhancers.
More to come
This story was aggregated from MMA Junkie